US Stock MarketDetailed Quotes

LIXT Lixte Biotechnology

Watchlist
  • 2.0600
  • -0.0100-0.48%
Close Nov 26 16:00 ET
4.63MMarket Cap-1190P/E (TTM)

Lixte Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-4.00%983.26K
-39.57%1.01M
-29.43%966.88K
-19.35%5.09M
-37.16%1.03M
-30.73%1.02M
8.02%1.67M
-17.18%1.37M
-6.09%6.31M
-19.37%1.63M
Selling and administrative expenses
-30.29%621.63K
-35.74%798.45K
-28.22%847.82K
-15.52%4.19M
-25.63%876.84K
-26.07%891.69K
-10.04%1.24M
-1.24%1.18M
-0.43%4.96M
-3.46%1.18M
-General and administrative expense
-30.29%621.63K
-35.74%798.45K
-28.22%847.82K
-15.52%4.19M
-25.63%876.84K
-26.07%891.69K
-10.04%1.24M
-1.24%1.18M
-0.43%4.96M
-3.46%1.18M
Research and development costs
172.96%361.63K
-50.71%210.71K
-37.03%119.06K
-33.44%898.1K
-67.14%149.07K
-51.36%132.49K
159.36%427.46K
-58.76%189.09K
-22.31%1.35M
-43.56%453.62K
Operating profit
4.00%-983.26K
39.57%-1.01M
29.43%-966.88K
19.35%-5.09M
37.16%-1.03M
30.73%-1.02M
-8.02%-1.67M
17.18%-1.37M
6.09%-6.31M
19.37%-1.63M
Net non-operating interest income expense
-92.98%388
-350.78%-1.92K
-474.96%-4.33K
-45.99%1.25K
-285.04%-6.2K
208.59%5.53K
275.69%766
148.39%1.15K
134.18%2.32K
177.33%3.35K
Non-operating interest income
-75.26%1.44K
-17.72%2.23K
-42.99%2.86K
56.19%17.49K
-43.47%3.95K
48.53%5.81K
1,320.94%2.71K
4,500.92%5.02K
1,688.34%11.2K
4,924.46%6.98K
Non-operating interest expense
275.99%1.05K
113.24%4.15K
86.12%7.19K
82.91%16.23K
179.09%10.15K
-86.83%279
210.69%1.95K
54.81%3.86K
19.71%8.88K
-18.68%3.64K
Other net income (expense)
-2,800.00%-3.16K
-81.98%158
-108.70%-116
157.91%1.95K
92.73%-148
91.62%-109
517.61%877
837.02%1.33K
-190.11%-3.37K
-2,412.35%-2.04K
Gain on sale of security
-2,800.00%-3.16K
-81.98%158
-108.70%-116
157.91%1.95K
92.73%-148
91.62%-109
517.61%877
837.02%1.33K
-190.11%-3.37K
-2,412.35%-2.04K
Income before tax
3.21%-986.03K
39.41%-1.01M
28.98%-971.32K
19.41%-5.09M
36.72%-1.03M
31.07%-1.02M
-7.89%-1.67M
17.46%-1.37M
6.18%-6.31M
19.61%-1.63M
Income tax
Net income
3.21%-986.03K
39.41%-1.01M
28.98%-971.32K
19.41%-5.09M
36.72%-1.03M
31.07%-1.02M
-7.89%-1.67M
17.46%-1.37M
6.18%-6.31M
19.61%-1.63M
Net income continuous Operations
3.21%-986.03K
39.41%-1.01M
28.98%-971.32K
19.41%-5.09M
36.72%-1.03M
31.07%-1.02M
-7.89%-1.67M
17.46%-1.37M
6.18%-6.31M
19.61%-1.63M
Minority interest income
Net income attributable to the parent company
3.21%-986.03K
39.41%-1.01M
28.98%-971.32K
19.41%-5.09M
36.72%-1.03M
31.07%-1.02M
-7.89%-1.67M
17.46%-1.37M
6.18%-6.31M
19.61%-1.63M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
3.21%-986.03K
39.41%-1.01M
28.98%-971.32K
19.41%-5.09M
36.72%-1.03M
31.07%-1.02M
-7.89%-1.67M
17.46%-1.37M
6.18%-6.31M
19.61%-1.63M
Basic earnings per share
10.20%-0.44
55.00%-0.45
47.56%-0.43
33.33%-2.66
58.16%-0.41
44.94%-0.49
-5.26%-1
31.67%-0.82
20.20%-3.99
34.67%-0.98
Diluted earnings per share
10.20%-0.44
55.00%-0.45
47.56%-0.43
33.33%-2.66
58.16%-0.41
44.94%-0.49
-5.26%-1
31.67%-0.82
20.20%-3.99
34.67%-0.98
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -4.00%983.26K-39.57%1.01M-29.43%966.88K-19.35%5.09M-37.16%1.03M-30.73%1.02M8.02%1.67M-17.18%1.37M-6.09%6.31M-19.37%1.63M
Selling and administrative expenses -30.29%621.63K-35.74%798.45K-28.22%847.82K-15.52%4.19M-25.63%876.84K-26.07%891.69K-10.04%1.24M-1.24%1.18M-0.43%4.96M-3.46%1.18M
-General and administrative expense -30.29%621.63K-35.74%798.45K-28.22%847.82K-15.52%4.19M-25.63%876.84K-26.07%891.69K-10.04%1.24M-1.24%1.18M-0.43%4.96M-3.46%1.18M
Research and development costs 172.96%361.63K-50.71%210.71K-37.03%119.06K-33.44%898.1K-67.14%149.07K-51.36%132.49K159.36%427.46K-58.76%189.09K-22.31%1.35M-43.56%453.62K
Operating profit 4.00%-983.26K39.57%-1.01M29.43%-966.88K19.35%-5.09M37.16%-1.03M30.73%-1.02M-8.02%-1.67M17.18%-1.37M6.09%-6.31M19.37%-1.63M
Net non-operating interest income expense -92.98%388-350.78%-1.92K-474.96%-4.33K-45.99%1.25K-285.04%-6.2K208.59%5.53K275.69%766148.39%1.15K134.18%2.32K177.33%3.35K
Non-operating interest income -75.26%1.44K-17.72%2.23K-42.99%2.86K56.19%17.49K-43.47%3.95K48.53%5.81K1,320.94%2.71K4,500.92%5.02K1,688.34%11.2K4,924.46%6.98K
Non-operating interest expense 275.99%1.05K113.24%4.15K86.12%7.19K82.91%16.23K179.09%10.15K-86.83%279210.69%1.95K54.81%3.86K19.71%8.88K-18.68%3.64K
Other net income (expense) -2,800.00%-3.16K-81.98%158-108.70%-116157.91%1.95K92.73%-14891.62%-109517.61%877837.02%1.33K-190.11%-3.37K-2,412.35%-2.04K
Gain on sale of security -2,800.00%-3.16K-81.98%158-108.70%-116157.91%1.95K92.73%-14891.62%-109517.61%877837.02%1.33K-190.11%-3.37K-2,412.35%-2.04K
Income before tax 3.21%-986.03K39.41%-1.01M28.98%-971.32K19.41%-5.09M36.72%-1.03M31.07%-1.02M-7.89%-1.67M17.46%-1.37M6.18%-6.31M19.61%-1.63M
Income tax
Net income 3.21%-986.03K39.41%-1.01M28.98%-971.32K19.41%-5.09M36.72%-1.03M31.07%-1.02M-7.89%-1.67M17.46%-1.37M6.18%-6.31M19.61%-1.63M
Net income continuous Operations 3.21%-986.03K39.41%-1.01M28.98%-971.32K19.41%-5.09M36.72%-1.03M31.07%-1.02M-7.89%-1.67M17.46%-1.37M6.18%-6.31M19.61%-1.63M
Minority interest income
Net income attributable to the parent company 3.21%-986.03K39.41%-1.01M28.98%-971.32K19.41%-5.09M36.72%-1.03M31.07%-1.02M-7.89%-1.67M17.46%-1.37M6.18%-6.31M19.61%-1.63M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 3.21%-986.03K39.41%-1.01M28.98%-971.32K19.41%-5.09M36.72%-1.03M31.07%-1.02M-7.89%-1.67M17.46%-1.37M6.18%-6.31M19.61%-1.63M
Basic earnings per share 10.20%-0.4455.00%-0.4547.56%-0.4333.33%-2.6658.16%-0.4144.94%-0.49-5.26%-131.67%-0.8220.20%-3.9934.67%-0.98
Diluted earnings per share 10.20%-0.4455.00%-0.4547.56%-0.4333.33%-2.6658.16%-0.4144.94%-0.49-5.26%-131.67%-0.8220.20%-3.9934.67%-0.98
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Top Gainers Yesterday
Top Gainers Yesterday
Intraday-3.65%